CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- 4 Planned sale CFO and Secretary sold 10,758 shares at an average $42.01 ($451,984)
- 4 Planned sale Chief Executive Officer sold 15,100 shares at an average $42.67 ($644,327)
- 4 Planned sale Chief Medical Officer sold 10,369 shares at $43.01 ($445,982)
- 4 Planned sale Chief Medical Officer sold 11,367 shares at an average $36.00 ($409,266)
- 4 Open-market buy Director bought 588,235 shares at $25.50 ($14,999,993)
- 4 Open-market buy Director bought 1,176,470 shares at $25.50 ($29,999,985)
- 4 Planned sale Chief Medical Officer sold 11,365 shares at $12.93 ($146,987)
- 4 Open-market sale CFO and Secretary sold 73,678 shares at an average $14.62 ($1,077,477)
- 4 Planned sale Chief Executive Officer sold 15,884 shares at $14.51 ($230,431)
- 4 Planned sale CFO and Secretary sold 10,758 shares at $14.45 ($155,454)
- 4 Planned sale Chief Medical Officer sold 11,366 shares at $14.59 ($165,879)
- 4 Planned sale Chief Medical Officer sold 11,366 shares at $14.60 ($165,931)
- 4 Planned sale Chief Medical Officer sold 11,366 shares at $15.29 ($173,774)
- 4 Option exercise Chief Medical Officer acquired 6,349 shares (option exercise)
- 4 Open-market buy Director bought 259,259 shares at $13.50 ($3,499,997)
- 4 Planned sale Chief Medical Officer sold 11,366 shares at an average $14.53 ($165,185)
- 4 Planned sale CFO and Secretary sold 10,757 shares at $12.06 ($129,684)
- 4 Planned sale Chief Executive Officer sold 15,319 shares at $12.19 ($186,803)
- 4 Planned sale Chief Medical Officer sold 55,771 shares at an average $15.76 ($879,008)
- 4 Open-market buy 10% owner bought 600,000 shares at $13.50 ($8,100,000)
Page 4 of 9 · 180 filings